![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Optimus Drugs Private Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their significant offerings is Rifaximin, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2020-303 - Rev 01
This Chemical Type CEP, issued on June 29, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2362 associated with this CEP further emphasizes